concentration in particular subdomains within a cell are
desired.
Fluorescence imaging is the most suitable method for
monitoring the local dynamics of zinc in living cells
because of its high spatial resolution.5 A straightforward
approach to achieve this is to attach a fluorescent zinc
sensor, which includes small organic molecules and pro-
tein-based indicators, to a target protein known to be
expressed on specific compartments within the cell. For
instance, Lippard et al. have reported SNAP-tag-based
site-specific zinc sensors, which have a benzylguanine unit
as a substrate of O6-alkylguanine transferase (AGT).6
They successfully carried out chemical labeling of the
AGT-fused protein expressed on mitochondria or Golgi
apparatuses and visualization of a change in zinc concen-
trations at a local intracellular region. Palmer et al. have
developed genetically targeted ratiometric zinc sensors
based on the fluorescence resonance energy transfer
(FRET) mechanism and have monitored the releasable
pool of Zn2þ in mitochondria.7 Although these genetically
encoded techniques are advantageous in that the sensor
distributions can be controlled precisely, the localization
strategies require a complex gene modification procedure,
including plasmid preparation and gene transfection, to
arrange the observation objects. Another strategy to loca-
lize fluorescent molecules to cellular subdomains is to use
fluorescent zinc sensors with a functional group that can
interact with specific organelles.8 A labile Zn2þ pool within
mitochondria has been monitored by using the mitochon-
dria-specific fluorescent zinc sensor Rhodzin-3, which is
based on a positively charged rhodamine fluorophore.8a
Although this approach may lack the certainty of sensor
localization within the target organelle, this method
requires no gene modification and, more importantly,
enables multicolor imaging of a single cell by changing
the fluorescence sensor moiety and organelle-targeting
group.9 However, only a few zinc sensors based on this
approach have been reported, and none have yet been
reported for the plasma membrane.
Figure 1. Molecular design of LF-Chol and its reference com-
pounds, LF-Me, F-chol, and F-Me.
O-triacetic acid)-based zinc-chelating structure in which
one acetic acid ligand is substituted with a 2-pyridylmethyl
group (L in Figure 1), because this pyridine-containing
chelatorhassufficient selectivityandhighaffinity(dissocia-
tion constant Kd sub-nM) for zinc ions, as we reported
previously.11 In addition, owing to the highly hydrophilic
character of the two remaining carboxyl groups of the zinc
chelator, the zinc sensor moiety is expected to be located at
the extracellular region in the vicinity of the plasma
membrane, which may allow for detection of zinc efflux
from the cell.
In order to evaluate the photophysical properties of
LF-Chol as a fluorescent zinc sensor, a reference molecule
LF-Me (shown in Figure 1), in which the TEG-cholesterol
moiety was substituted with a simple methyl group,
was initially prepared (Scheme 1). Compound 2 was pre-
pared according to the improved procedure we reported
previously.11 It was necessary to transform the tert-butyl
esters in compound 2 into the corresponding ethyl esters 3
because the formation of the xanthene platform as a
fluorophore by FriedelꢀCrafts reaction would be carried
out under acidic conditions. Formylation of ethyl ester 3
under Vilsmeier conditions followed bythe FriedelꢀCrafts
reaction afforded fluorescein derivative 5, which is also
used for the synthesis of LF-Chol. Methylation of the
phenolic oxygen atom and subsequent hydrolysis afforded
LF-Me, which was purified by semipreparative reversed-
phase HPLC (H2O/CH3CN containing 0.1% TFA) for
spectroscopic measurements.12
In this context, we designed and synthesized a new
small-molecule-based fluorescent zinc sensor, LF-Chol
(Figure 1). Because cholesterol has been known to prefer-
entially interact with a subset of membrane lipids,10 we
expected that the conjugated fluorescent zinc sensor moi-
ety of LF-Chol would localize specifically to the cell
membrane. We chose an APTRA (o-aminophenol-N,N,
(5) (a) Jiang, P. J.; Guo, Z. J. Coord. Chem. Rev. 2004, 248, 205–229.
(b) Kikuchi, K.; Komatsu, K.; Nagano, T. Curr. Opin. Chem. Biol. 2004,
8, 182–191. (c) Que, E. L.; Domaille, D. W.; Chang, C. J. Chem. Rev.
2008, 108, 1517–1549. (d) Tomat, E.; Lippard, S. J. Curr. Opin. Chem.
Biol. 2010, 14, 225–230.
(6) Tomat, E.; Nolan, E. M.; Jaworski, J.; Lippard, S. J. J. Am. Chem.
Soc. 2008, 130, 15776–15777.
(7) Dittmer, P. J.; Miranda, J. G.; Gorski, J. A.; Palmer, A. E. J. Biol.
Chem. 2009, 284, 16289–16297.
(8) (a) Sensi, S. L.; Ton-That, D.; Weiss, J. H.; Rothe, A.; Gee, K. R.
Cell Calcium 2003, 34, 281–284. (b) Dodani, S. C.; Leary, S. C.; Cobine,
P. A.; Winge, D. R.; Chang, C. J. J. Am. Chem. Soc. 2011, 133, 8606–
8616.
(9) Rosania, G. R.; Lee, J. W.; Ding, L.; Yoon, H. S.; Chang, Y. T. J.
Am. Chem. Soc. 2003, 125, 1130–1131.
(11) Taki, M.; Watanabe, Y.; Yamamoto, Y. Tetrahedron Lett. 2009,
50, 1345–1347.
(12) Since available amounts of LF-Me and LF-Chol were too small
for 13C and 1H/13C NMR analyses, respectively, the overall purity of the
product was confirmed by HPLC and the product was identified by mass
analysis (see Supporting Information).
(10) Wustner, D. Chem. Phys. Lipids 2007, 146, 1–25.
Org. Lett., Vol. 13, No. 17, 2011
4559